This American Airlines Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

  • Wedbush analyst David Nierengarten downgraded the rating for Ikena Oncology, Inc. IKNA from Outperform to Neutral, while slashing the price target from $8 to $2. Ikena Oncology shares closed at $1.33 on Tuesday. See how other analysts view this stock.
  • Wells Fargo analyst Finian O’Shea downgraded Goldman Sachs BDC, Inc. GSBD from Equal-Weight to Underweight and cut the price target from $15 to $14. Goldman Sachs BDC shares fell 0.1% to settle at $15.18 on Tuesday. See how other analysts view this stock.
  • Citigroup analyst Benjamin Gerlinger downgraded the rating for Bank OZK OZK from Buy to Sell, while cutting the price target from $57 to $37. Bank OZK shares fell 0.7% to settle at $46.19 on Tuesday. See how other analysts view this stock. See how other analysts view this stock.
  • Jefferies analyst Sheila Kahyaoglu downgraded American Airlines Group Inc. AAL from Buy to Hold and slashed the price target from $17 to $12. American Airlines shares fell 2.9% to close at $13.44 on Tuesday. See how other analysts view this stock.
  • Baird analyst David Manthey downgraded the rating for WESCO International, Inc. WCC from Outperform to Neutral, while lowering the price target from $200 to $195. WESCO shares fell 3% to settle at $185.52 on Tuesday. See how other analysts view this stock.

Check This Out: Top 3 Tech Stocks That May Implode In May

Loading...
Loading...
AAL Logo
AALAmerican Airlines Group Inc
$10.731.66%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum
21.46
Growth
74.27
Quality
Not Available
Value
44.93
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm

Comments
Loading...